financetom
Business
financetom
/
Business
/
Meta Platforms Served Cease and Desist Letter From Austrian Advocacy Group Over Planned AI Data Use in Europe
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta Platforms Served Cease and Desist Letter From Austrian Advocacy Group Over Planned AI Data Use in Europe
May 26, 2025 7:35 AM

07:40 AM EDT, 05/14/2025 (MT Newswires) -- Meta Platforms ( META ) was served a cease and desist letter from Austrian advocacy group Noyb over the social media company's plans to use personal data from Instagram and Facebook users to train its new AI systems without opt-in consent, Noyb said Wednesday.

The advocacy group said it has sent a formal settlement proposal to Meta.

The group said that if injunctions are filed and won, Meta may be liable for damages to consumers, with damages possibly reaching "billions." Additionally, if an injunction is won, the company would be forced to delete any illegally trained AI system, the group added.

The group said it estimates potential liabilities could reach 200 billion euros if European courts award 500 euros in non-material damages per user, based on Meta's estimated 400 million monthly active users in Europe.

Meta Platforms ( META ) did not immediately respond to requests for comment from MT Newswires.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ING Previews Wednesday's Bank of Canada Policy Decision
ING Previews Wednesday's Bank of Canada Policy Decision
Jul 24, 2024
06:49 AM EDT, 07/24/2024 (MT Newswires) -- ING expects the Bank of Canada (BoC) to cut the policy rate by 25bps Wednesday at 9:45 a.m. ET. This is almost entirely priced in by financial markets (21bps), which currently expect 65bps of easing by year-end, wrote the bank in a note to clients. Consensus isn't unanimous, but the majority of economists...
Otis Worldwide Q2 Earnings Rise, Net Sales Fall; Updates 2024 Outlook
Otis Worldwide Q2 Earnings Rise, Net Sales Fall; Updates 2024 Outlook
Jul 24, 2024
06:50 AM EDT, 07/24/2024 (MT Newswires) -- Otis Worldwide ( OTIS ) reported Q2 adjusted non-GAAP earnings Wednesday of $1.06, up from $0.92 a year earlier. Analysts polled by Capital IQ expected $1.03. Net sales for the quarter ended June 30 was $3.60 billion, down from $3.72 billion a year earlier. Analysts surveyed by Capital IQ expected $3.73 billion. Otis...
Biogen and Sage to scrap neurological disorder drug development after trial failure
Biogen and Sage to scrap neurological disorder drug development after trial failure
Jul 24, 2024
July 24 (Reuters) - Biogen and Sage Therapeutics ( SAGE ) do not plan to conduct further studies for their neurological disorder drug after it failed in a mid-stage trial, the drugmakers said on Wednesday. The experimental drug, SAGE-324, was being studied as a treatment for essential tremor, a disorder that causes uncontrollable shaking of the hands, arms and other...
Tesla Second-Quarter Earnings Miss Estimates Amid Lower Prices
Tesla Second-Quarter Earnings Miss Estimates Amid Lower Prices
Jul 24, 2024
06:46 AM EDT, 07/24/2024 (MT Newswires) -- Tesla (TSLA) shares dropped early Wednesday as the electric vehicle manufacturer's second-quarter earnings fell short of market expectations, impacted by lower vehicle prices and restructuring charges. Adjusted earnings declined to $0.52 per share for the June quarter from $0.91 the year before, the company said late Tuesday, trailing the Capital IQ-polled consensus of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved